Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma

NCT01249690 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib,Pirarubicin,Dexamethasone
DRUG: Thalidomide,Pirarubicin,Dexamethasone

Sponsor

Second Military Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]